Literature DB >> 9244332

Clinical recognition and management of patients exposed to biological warfare agents.

D R Franz1, P B Jahrling, A M Friedlander, D J McClain, D L Hoover, W R Bryne, J A Pavlin, G W Christopher, E M Eitzen.   

Abstract

Concern regarding the use of biological agents--bacteria, viruses, or toxins--as tools of warfare or terrorism has led to measures to deter their use or, failing that, to deal with the consequences. Unlike chemical agents, which typically lead to violent disease syndromes within minutes at the site of exposure, diseases resulting from biological agents have incubation periods of days. Therefore, rather than a paramedic, it will likely be a physician who is first faced with evidence of the results of a biological attack. We provide here a primer on 10 classic biological warfare agents to increase the likelihood of their being considered in a differential diagnosis. Although the resultant diseases are rarely seen in many countries today, accepted diagnostic and epidemiologic principles apply; if the cause is identified quickly, appropriate therapy can be initiated and the impact of a terrorist attack greatly reduced.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9244332     DOI: 10.1001/jama.278.5.399

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  128 in total

Review 1.  Bioterrorism: implications for the clinical microbiologist.

Authors:  W F Klietmann; K L Ruoff
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Coping with bioterrorism is difficult, but may help us respond to new epidemics.

Authors:  P Rosen
Journal:  BMJ       Date:  2000-01-08

3.  Comparison of dissociation-enhanced lanthanide fluorescent immunoassays to enzyme-linked immunosorbent assays for detection of staphylococcal enterotoxin B, Yersinia pestis-specific F1 antigen, and Venezuelan equine encephalitis virus.

Authors:  D R Smith; C A Rossi; T M Kijek; E A Henchal; G V Ludwig
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

4.  Pulmonary Manifestations of Bioterrorism.

Authors:  Renuka Heddurshetti; Wadchara Pumpradit; Larry I. Lutwick
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

Review 5.  Recognizing the real threat of biological terror.

Authors:  Richard P Wenzel
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

Review 6.  [Bioterrorism and primary care].

Authors:  M A Mayer Pujadas; M J Alvarez Pasquín; J Gómez Marco; J Redondo Sánchez; J Muñoz Gutiérrez; M Cereceda Ferrés; C Batalla Martínez; E Comín Bertrán; A Pareja Bezares; R Piñeiro Guerrero; V Niño Martín; J Arranz Izquierdo; P Carceller; E Nodar Martín; J Ortega Martínez; J Vázquez Villegas
Journal:  Aten Primaria       Date:  2002-10-15       Impact factor: 1.137

7.  Development of the small-molecule antiviral ST-246 as a smallpox therapeutic.

Authors:  Douglas W Grosenbach; Robert Jordan; Dennis E Hruby
Journal:  Future Virol       Date:  2011-05       Impact factor: 1.831

8.  Generation of the Brucella melitensis ORFeome version 1.1.

Authors:  Amélie Dricot; Jean-François Rual; Philippe Lamesch; Nicolas Bertin; Denis Dupuy; Tong Hao; Christophe Lambert; Régis Hallez; Jean-Marc Delroisse; Jean Vandenhaute; Ignacio Lopez-Goñi; Ignacio Moriyon; Juan M Garcia-Lobo; Félix J Sangari; Alastair P Macmillan; Sally J Cutler; Adrian M Whatmore; Stephanie Bozak; Reynaldo Sequerra; Lynn Doucette-Stamm; Marc Vidal; David E Hill; Jean-Jacques Letesson; Xavier De Bolle
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

9.  Essential role for the BacA protein in the uptake of a truncated eukaryotic peptide in Sinorhizobium meliloti.

Authors:  Victoria L Marlow; Andreas F Haag; Hajime Kobayashi; Vivien Fletcher; Marco Scocchi; Graham C Walker; Gail P Ferguson
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

10.  Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL.

Authors:  Dola Sengupta; Alicia Koblansky; Jennifer Gaines; Tim Brown; A Phillip West; Dekai Zhang; Tak Nishikawa; Sung-Gyoo Park; R Martin Roop; Sankar Ghosh
Journal:  J Immunol       Date:  2009-12-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.